VanEck Biotech ETF
BBH
BBH
115 hedge funds and large institutions have $146M invested in VanEck Biotech ETF in 2022 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 24 increasing their positions, 35 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
31% less repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 35
43% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 21
Holders
115
Holding in Top 10
–
Calls
$1.02M
Puts
$243K
Top Buyers
| 1 | +$8.98M | |
| 2 | +$2.92M | |
| 3 | +$2.47M | |
| 4 |
CCA
Conservest Capital Advisors
Wynnewood,
Pennsylvania
|
+$1.86M |
| 5 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
+$1.69M |
Top Sellers
| 1 | -$9.89M | |
| 2 | -$2.7M | |
| 3 | -$2.61M | |
| 4 |
FFN
Focus Financial Network
Minneapolis,
Minnesota
|
-$2.15M |
| 5 |
CIBC Private Wealth Group
Atlanta,
Georgia
|
-$1.23M |